Journal
Today’s dr visit was good, just an infusion. But there is a clinical trail that they believe I am a good candidate for. We go to UNC CH on June 25th to speak to the dr heading it up. The trial is NCT05733611: RP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRC. They did say we will consider gemcitabine next line of therapy if required in future.
Read the latest Journal Entry
3 Hearts